Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
Reviews

Mesothelin

A New Target for Immunotherapy

Raffit Hassan, Tapan Bera and Ira Pastan
Raffit Hassan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tapan Bera
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ira Pastan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-03-0801 Published June 2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Schematics showing maturation of mesothelin protein. Precursor protein for mesothelin is synthesized as a 622-amino acid polypeptide with a calculated molecular mass of 77 kDa. The potential signal peptide (SP) and the glycosylphosphatidyl inositol anchor signal sequence (GASS) are predicted at the NH2 terminus and the COOH terminus, respectively. The precursor protein has four predicted glycosylation sites (CHO) and a furin cleavage site (RR). Cleavage at the furin site generates membrane-bound mesothelin (green) and the secretory protein megakaryocyte-potentiating factor (red).

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Schematics describing the mesothelin gene and the proteins it encodes. A, genomic organization of mesothelin gene. There are 17 exons (filled boxes) in the mesothelin gene. B, drawing of three different forms of mesothelin protein described in the database. Mesothelin is the most common variant and is predicted to be membrane-bound; mesothelin V-1 has an additional 8 amino acids (yellow) and is also predicted to be bound to the membrane. Mesothelin V-2 has a modified COOH terminus (orange), lacks the glycosylphosphatidyl inositol anchor signal sequence, and is predicted to be secreted.

PreviousNext
Back to top
Clinical Cancer Research: 10 (12)
June 2004
Volume 10, Issue 12
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mesothelin
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
Citation Tools
Mesothelin
Raffit Hassan, Tapan Bera and Ira Pastan
Clin Cancer Res June 15 2004 (10) (12) 3937-3942; DOI: 10.1158/1078-0432.CCR-03-0801

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Mesothelin
Raffit Hassan, Tapan Bera and Ira Pastan
Clin Cancer Res June 15 2004 (10) (12) 3937-3942; DOI: 10.1158/1078-0432.CCR-03-0801
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • ISOLATION OF MAB K1 AND CLONING OF ITS 40-KDA ANTIGEN, MESOTHELIN
    • MPF
    • SOLUBLE MESOTHELIN
    • BIOLOGICAL FUNCTION OF MESOTHELIN
    • MESOTHELIN EXPRESSION IN HUMAN MALIGNANCIES
    • MESOTHELIN AS A TARGET FOR TUMOR- SPECIFIC IMMUNOTHERAPY
    • CLINICAL TRIALS OF SS1(DSFV)-PE38 (SS1P)
    • MESOTHELIN AS A THERAPEUTIC CANCER VACCINE
    • SOLUBLE MESOTHELIN AS A DIAGNOSTIC TUMOR MARKER
    • MESOTHELIN IMMUNOHISTOCHEMISTRY FOR TUMOR DIAGNOSIS
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • ctDNA for Cancer Immunotherapy
  • Innate and Acquired Resistance to Anti-EGFR Therapy
  • The Evolving Modern Management of Brain Metastasis
Show more Reviews
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement